Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

BSH 2019 | Defining the role of NFIC in AML

Namrata Rastogi, PhD, Cardiff University, Cardiff, UK, discusses her research into nuclear factor I/C (NFIC), a transcription factor, and it’s role in acute myeloid leukemia (AML). This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.